IVRN (Innoveren Scientific) Cyclically Adjusted FCF per Share: $-248.79 (As of Sep. 2023)


IVRN Innoveren Scientific Inc IVRN
16 GF Score
Price $0.00
View Full Analysis

What is Innoveren Scientific Cyclically Adjusted FCF per Share?

Innoveren Scientific IVRN 16 Cyclically Adjusted FCF per Share is $-248.79 as of Sep. 2023. GuruFocus rates IVRN with a GF Score™ of 16/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Innoveren Scientific's adjusted free cash flow per share for the three months ended in Sep. 2023 was $-0.478. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-248.79 for the trailing ten years ended in Sep. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-05), Innoveren Scientific's current stock price is $0.0007. Innoveren Scientific's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2023 was $-248.79. Innoveren Scientific's Cyclically Adjusted Price-to-FCF of today is .


Innoveren Scientific  (OTCPK:IVRN) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Innoveren Scientific Cyclically Adjusted FCF per Share Related Terms


Innoveren Scientific Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Innoveren Scientific's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innoveren Scientific Cyclically Adjusted FCF per Share Chart

Innoveren Scientific Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Innoveren Scientific Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -248.79

IVRN vs GNCA, ISCO, FNAM: Cyclically Adjusted FCF per Share Comparison

For the Biotechnology subindustry, Innoveren Scientific's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innoveren Scientific Cyclically Adjusted Price-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innoveren Scientific's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Innoveren Scientific's Cyclically Adjusted Price-to-FCF falls into.


IVRN
16GF Score
Innoveren Scientific Inc IVRN
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innoveren Scientific Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Innoveren Scientific's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-0.478/307.7890*307.7890
=-0.478

Current CPI (Sep. 2023) = 307.7890.

Innoveren Scientific Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201312 0.000 233.049 0.000
201403 -46.556 236.293 -60.643
201406 -79.222 238.343 -102.305
201409 -64.444 238.031 -83.330
201412 -119.000 234.812 -155.984
201503 -138.111 236.119 -180.032
201506 -214.500 238.638 -276.656
201509 -130.091 237.945 -168.277
201512 -90.000 236.525 -117.117
201603 -88.167 238.132 -113.957
201606 -101.462 241.018 -129.571
201609 -117.000 241.428 -149.160
201612 -106.929 241.432 -136.318
201703 -91.125 243.801 -115.042
201706 -67.000 244.955 -84.186
201709 -60.571 246.819 -75.533
201712 -75.909 246.524 -94.774
201803 -45.765 249.554 -56.445
201806 -6.824 251.989 -8.335
201809 -23.130 252.439 -28.202
201812 -9.000 251.233 -11.026
201903 -45.151 254.202 -54.669
201906 -25.958 256.143 -31.192
201909 -15.646 256.759 -18.756
201912 -45.237 256.974 -54.182
202003 -18.910 258.115 -22.549
202006 -23.728 257.797 -28.329
202009 -1.696 260.280 -2.006
202012 -14.262 260.474 -16.853
202103 -10.227 264.877 -11.884
202106 -10.435 271.696 -11.821
202109 -8.782 274.310 -9.854
202112 -5.043 278.802 -5.567
202203 -5.231 287.504 -5.600
202206 -2.923 296.311 -3.036
202209 -1.039 296.808 -1.077
202212 -0.230 296.797 -0.239
202303 -0.585 301.836 -0.597
202306 -0.129 305.109 -0.130
202309 -0.478 307.789 -0.478

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-248.79 mean?
Innoveren Scientific (IVRN) has a Cyclically Adjusted FCF per Share of $-248.79 as of Sep. 2023. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Innoveren Scientific and its competitors.
Is Innoveren Scientific's Cyclically Adjusted FCF per Share too high?
Innoveren Scientific's current Cyclically Adjusted FCF per Share is $-248.79. Overall, Innoveren Scientific has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Innoveren Scientific's Cyclically Adjusted FCF per Share compare to GNCA and ISCO?
Innoveren Scientific's Cyclically Adjusted FCF per Share of $-248.79 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Biotechnology company?
A good Cyclically Adjusted FCF per Share depends on the Biotechnology industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Innoveren Scientific and its competitors. Innoveren Scientific's current Cyclically Adjusted FCF per Share is $-248.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innoveren Scientific stock overvalued right now?
Innoveren Scientific (IVRN) has a current Cyclically Adjusted FCF per Share of $-248.79. The current Cyclically Adjusted FCF per Share is $-248.79. Innoveren Scientific's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Innoveren Scientific (IVRN), the current Cyclically Adjusted FCF per Share is $-248.79 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innoveren Scientific Business Description

Address 2202 N West Shore Boulevard, Suite 200, Tampa, FL, USA, 33607
Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
16GF Score

Get the complete analysis for IVRN

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price